FDA Commissioner Scott Gottlieb, M.D., today issued an update on the agency’s efforts to address ongoing shortages of intravenous saline. “Based on the information we’re receiving from companies and the actions we’ve taken at FDA, we continue to expect that the shortage of IV fluids will improve in the coming weeks and months,” Gottlieb said. “In addition to working with manufacturers to ensure that their Puerto Rico facilities can operate at full capacity, we’ve worked with manufacturers such as Baxter and B. Braun to import product into the U.S. from their foreign facilities including most recently from a Baxter facility in Brazil. We are also looking at additional potential import sites for both small and larger volume IV saline bags. Further, our approval of IV saline products from additional companies, specifically Fresenius Kabi and Laboratorios Grifols, is expected to result in increasing product supply in U.S. market in the next several weeks.” FDA also is working with companies to see if expiration dates for shortage products can be safely extended, and is assessing supply and demand for empty IV bags and the capacity of manufacturers of these bags to ramp up their production, he said.

Related News Articles

Headline
An estimated 23 percent of outpatient antibiotic prescriptions filled by privately insured children and non-elderly adults in the United States in 2016 were…
Insights and Analysis
Also in this weekly roundup of health-related news: treatment options scarce as meth deaths flare; app makes donating blood easier
Headline
Hospitals and health systems may apply through Feb. 19 for the 2019 AHA Equity of Care Award, which recognizes organizations participating in the AHA's #…
Insights and Analysis
At last month’s AHA Executive Forum, Kimberlydawn Wisdom, M.D., senior vice president of community health and equity and chief wellness and diversity officer…
Headline
The AHA today submitted to the Food and Drug Administration legislative, regulatory and best practice recommendations to address new and chronic prescription…
Headline
A coalition of 40 health care and public health organizations, including the AHA, today urged the Senate to quickly pass the Pandemic and All-Hazards…